Source: FSC-APHSS
By: Company Press Release
As a result of a performer testing positive for syphilis, APHSS.org providers are administering the standard RRP syphilis test that is approved by the FDA for preliminary diagnosis. A negative test does not mean you are safe to work. It is important to note that this test has a large window – as much as 90 days – and therefore cannot be relied upon to diagnose an acute (recent) syphilis infection.
More importantly, a person with an acute infection can be contagious and still test negative. We cannot rely on these tests alone to determine your availability to work. This test only provides our doctors with a baseline from which to base further testing or treatment options.
FSC has called a temporary moratorium on production and asks that all producers and performers honor this moratorium.
The good news is that syphilis is easily treatable-it requires treatment with antibiotics. APHSS’ doctors network has determined that prophylactic treatment for syphilis for all performers is warranted. The shots have been ordered from the pharmacy and by Wednesday, APHSS will have set up a network of medical professionals to administer the shots. Locations for performers to get the shots will be announced tomorrow, August 21.
You will be available to work 10 after you receive the shot. You will not be charged for the treatment. Manwin has agreed to cover cost of the shots for performers. Other producers contributing to cover the cost of treatment include Evil Angel, Girlfriend Films, Kink.com, Vivid Pictures and Gamma Entertainment. Still more producers are offering to contribute – this is an industry-wide effort by producers to ensure the safety of the performers.
We will keep you posted as to any new developments and about the protocol for confirming that you have been tested and have had the shot. Thank you for your patience as we put these preventative treatment protocols in place. Your health is very important to us.
Sincerely,
Diane Duke
FSC Executive Director
